WO2003006429A1 - Synthesis of taxol enhancers - Google Patents
Synthesis of taxol enhancers Download PDFInfo
- Publication number
- WO2003006429A1 WO2003006429A1 PCT/US2002/021716 US0221716W WO03006429A1 WO 2003006429 A1 WO2003006429 A1 WO 2003006429A1 US 0221716 W US0221716 W US 0221716W WO 03006429 A1 WO03006429 A1 WO 03006429A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- substituted
- nhr
- phenyl
- aliphatic
- Prior art date
Links
- 0 *CC(N(*)*(*)C(*C(N(N(*)C(*)=S)O*)=O)=O)=S Chemical compound *CC(N(*)*(*)C(*C(N(N(*)C(*)=S)O*)=O)=O)=S 0.000 description 1
- GEASCWHPMRLZNR-UHFFFAOYSA-N CC(C(NN(C)C1SC1c(cccc1OC)c1OC)=O)C(NN(C)C(c1cccc(OC)c1OC)=S)=O Chemical compound CC(C(NN(C)C1SC1c(cccc1OC)c1OC)=O)C(NN(C)C(c1cccc(OC)c1OC)=S)=O GEASCWHPMRLZNR-UHFFFAOYSA-N 0.000 description 1
- XLTZYCMIMIOJTQ-UHFFFAOYSA-O CC1(C(N(c2ccccc2)NC(CC(NN(C(c2ccccc2OC(C)=O)=S)c2ccccc2)=O)=O)=S)C([OH+]C(C)=O)=CC=CC1 Chemical compound CC1(C(N(c2ccccc2)NC(CC(NN(C(c2ccccc2OC(C)=O)=S)c2ccccc2)=O)=O)=S)C([OH+]C(C)=O)=CC=CC1 XLTZYCMIMIOJTQ-UHFFFAOYSA-O 0.000 description 1
- LYWWILDQHVTJKY-UHFFFAOYSA-N CN(C(c(cc1)ccc1Cl)=S)NC(CC(NN(C)C(c(cc1)ccc1Cl)=S)=O)=O Chemical compound CN(C(c(cc1)ccc1Cl)=S)NC(CC(NN(C)C(c(cc1)ccc1Cl)=S)=O)=O LYWWILDQHVTJKY-UHFFFAOYSA-N 0.000 description 1
- INAMTJOONRVRME-UHFFFAOYSA-O NC(CC([NH3+])=[O]S=C(CCCC(O)=O)Nc1ccccc1)=[O]S=C(CCCC(O)=O)Nc1ccccc1 Chemical compound NC(CC([NH3+])=[O]S=C(CCCC(O)=O)Nc1ccccc1)=[O]S=C(CCCC(O)=O)Nc1ccccc1 INAMTJOONRVRME-UHFFFAOYSA-O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/56—Amides of thiocarboxylic acids having nitrogen atoms of thiocarboxamide groups further bound to another hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/83—Thioacids; Thioesters; Thioamides; Thioimides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2004-7000333A KR20040026679A (en) | 2001-07-10 | 2002-07-10 | Synthesis of taxol enhancers |
EP02746946A EP1406868A1 (en) | 2001-07-10 | 2002-07-10 | Synthesis of taxol enhancers |
CA002453415A CA2453415A1 (en) | 2001-07-10 | 2002-07-10 | Synthesis of taxol enhancers |
JP2003512201A JP2004534847A (en) | 2001-07-10 | 2002-07-10 | Synthesis of taxol enhancer |
AU2002316625A AU2002316625B2 (en) | 2001-07-10 | 2002-07-10 | Synthesis of taxol enhancers |
MXPA04000245A MXPA04000245A (en) | 2001-07-10 | 2002-07-10 | Synthesis of taxol enhancers. |
NO20040053A NO20040053L (en) | 2001-07-10 | 2004-01-07 | Synthesis of taxol enhancers |
AU2006203689A AU2006203689A1 (en) | 2001-07-10 | 2006-08-24 | Synthesis of taxol enhancers |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30431801P | 2001-07-10 | 2001-07-10 | |
US60/304,318 | 2001-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003006429A1 true WO2003006429A1 (en) | 2003-01-23 |
Family
ID=23176001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/021716 WO2003006429A1 (en) | 2001-07-10 | 2002-07-10 | Synthesis of taxol enhancers |
Country Status (11)
Country | Link |
---|---|
US (4) | US6825235B2 (en) |
EP (1) | EP1406868A1 (en) |
JP (1) | JP2004534847A (en) |
KR (1) | KR20040026679A (en) |
CN (2) | CN100398516C (en) |
AU (2) | AU2002316625B2 (en) |
CA (1) | CA2453415A1 (en) |
MX (1) | MXPA04000245A (en) |
NO (1) | NO20040053L (en) |
TW (1) | TWI252847B (en) |
WO (1) | WO2003006429A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008504264A (en) * | 2004-06-23 | 2008-02-14 | シンタ ファーマスーティカルズ コーポレイション | Bis (thio-hydrazide amide) salts for cancer treatment |
WO2009073148A2 (en) * | 2007-11-28 | 2009-06-11 | Synta Pharmaceuticals Corp. | Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide) |
WO2009123704A2 (en) * | 2008-03-31 | 2009-10-08 | Synta Pharmaceuticals Corp. | Process for preparing bis(thiohydrazide amides) |
US7645904B2 (en) | 2006-09-15 | 2010-01-12 | Synta Pharmaceuticals Corp. | Purification of bis(thiohydrazide amides) |
US7652168B2 (en) | 2001-07-10 | 2010-01-26 | Synta Pharmaceuticals Corp. | Synthesis of taxol enhancers |
US7671092B2 (en) | 2001-07-10 | 2010-03-02 | Synta Pharmaceuticals Corp. | Paclitaxel enhancer compounds |
US7678832B2 (en) | 2005-08-16 | 2010-03-16 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amide) formulation |
US7750042B2 (en) | 2001-07-10 | 2010-07-06 | Synta Pharmaceuticals Corp. | Paclitaxel enhancer compound |
US7763658B2 (en) | 2003-01-15 | 2010-07-27 | Synta Pharmaceuticals Corp. | Treatment for cancers |
US7939564B2 (en) | 2006-08-31 | 2011-05-10 | Synta Pharmaceuticals Corp. | Combination with bis(thiohydrazide amides) for treating cancer |
US8017654B2 (en) | 2005-04-15 | 2011-09-13 | Synta Pharmaceuticals Corp. | Combination cancer therapy with bis(thiohydrazide) amide compounds |
WO2013144228A1 (en) | 2012-03-29 | 2013-10-03 | Basf Se | Pesticidal methods using heterocyclic compounds and derivatives for combating animal pests |
US9156783B2 (en) | 2006-08-21 | 2015-10-13 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8148426B2 (en) * | 2004-11-19 | 2012-04-03 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amides) for increasing Hsp70 expression |
WO2006062732A2 (en) * | 2004-11-19 | 2006-06-15 | Synta Pharmaceuticals Corp. | Compounds acting at the centrosome |
CA2603314A1 (en) * | 2005-04-15 | 2006-10-26 | Synta Pharmaceuticals Corp. | Methods of increasing natural killer cell activity for therapy |
BRPI0611262A2 (en) * | 2005-05-16 | 2010-08-24 | Synta Pharmaceuticals Corp | Methods of Preparing a Bis (Thiohydrazide Amide) Di-Salt |
WO2008024299A2 (en) * | 2006-08-21 | 2008-02-28 | Synta Pharmaceuticals Corp. | Combination with bis(thiohydrazide amides) for treating cancer |
AU2007288336B2 (en) * | 2006-08-21 | 2011-04-21 | Synta Pharmaceuticals Corp. | Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma |
WO2008024305A2 (en) * | 2006-08-21 | 2008-02-28 | Synta Pharmaceuticals Corp. | Bis (thiohydrazide amides) for treating melanoma |
CN101134057B (en) * | 2006-09-01 | 2011-04-27 | 中山大学 | Compound medicament of natural plant extract containing paclitaxel and anticancer application thereof |
WO2008033300A2 (en) * | 2006-09-11 | 2008-03-20 | Synta Pharmaceuticals Corp. | Bis (thiohydrazide amides) formulation |
US9498528B2 (en) * | 2006-09-13 | 2016-11-22 | Genzyme Corporation | Treatment of multiple sclerosis (MS) |
WO2008082579A1 (en) * | 2007-01-03 | 2008-07-10 | Synta Pharmaceuticals Corp. | Method for treating cancer |
US8618170B2 (en) | 2007-11-09 | 2013-12-31 | Synta Pharmaceuticals Corp. | Oral formulations of bis(thiohydrazide amides) |
WO2009105257A1 (en) | 2008-02-21 | 2009-08-27 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
CN102256949B (en) | 2008-10-22 | 2014-09-24 | 辛塔医药品有限公司 | Transition metal complexes of a bis[thiohydrazide amide] compound |
AU2009308502B2 (en) | 2008-10-22 | 2013-08-01 | Synta Pharmaceuticals Corp. | Transition metal complexes of bis[thiohydrazide amide] compounds |
US8525776B2 (en) * | 2008-10-27 | 2013-09-03 | Lenovo (Singapore) Pte. Ltd | Techniques for controlling operation of a device with a virtual touchscreen |
WO2010065512A2 (en) | 2008-12-01 | 2010-06-10 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
WO2011069159A2 (en) | 2009-12-04 | 2011-06-09 | Synta Pharmaceuticals Corp. | Bis[thiohydrazide amide] compounds for treating leukemia |
US8815945B2 (en) | 2010-04-20 | 2014-08-26 | Masazumi Nagai | Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers |
CA2854186A1 (en) | 2011-11-10 | 2013-05-16 | Jim SANG | Administration of a bis(thiohydrazide amide) compound for treating cancers |
WO2013103795A1 (en) | 2012-01-05 | 2013-07-11 | The Board Of Trustees Of The Leland Stanford Junior University | Bis (thiohydrazide amide) compounds for treating cancers |
CN115572249A (en) * | 2022-09-21 | 2023-01-06 | 南京红云生物科技有限公司上海分公司 | Copper ion chelating agent and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH482394A (en) * | 1966-09-14 | 1969-12-15 | Shell Int Research | Herbicidal agent |
Family Cites Families (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2097737A5 (en) | 1970-07-14 | 1972-03-03 | Berlin Chemie Veb | Virustatic 4-substd 1-acylthiosemicarbazides -from carboxylic acid - hydrazide and isothiocyanates or from carboxylic acid chloride and 4- |
DE2037257A1 (en) | 1970-07-28 | 1972-02-03 | Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt | Poly-(5-amino-1,3,4-thiadiazol-2-yl) derivs prepn - intermediates for drug and polymer prodn |
GB1272920A (en) | 1971-03-15 | 1972-05-03 | Berlin Chemie Veb | New thiosemicarbazides |
US4012360A (en) * | 1973-12-03 | 1977-03-15 | Ciba-Geigy Corporation | Bis-salicyloyl-dicarboxylic acid dihydrazides as stabilizers for polyolefines |
JPS5091056A (en) | 1973-12-17 | 1975-07-21 | ||
US4822777A (en) * | 1987-02-27 | 1989-04-18 | Liposome Technology, Inc. | Amphotericin B/cholesterol sulfate composition |
JP2767241B2 (en) | 1987-04-15 | 1998-06-18 | ロ−ム アンド ハ−ス コンパニ− | Pesticidal N- (optionally substituted) -N'-substituted-N, N'-disubstituted hydrazines |
US4826866A (en) * | 1987-11-02 | 1989-05-02 | A. H. Robins Company, Incorporated | 3-amino-5-methyl-1H-pyrazole-4-carboxylic acids and esters thereof as anticonvulsants, muscle relaxants and anxiolytics |
EP0403524B1 (en) * | 1988-03-09 | 1993-02-10 | Cis Bio International | Preparation of nitruro compounds usable as radio-pharmaceutical products |
US6013836A (en) * | 1992-02-28 | 2000-01-11 | Rohm And Haas Company | Insecticidal N'-substituted-N,N'-disubstitutedhydrazines |
FR2697752B1 (en) | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Antitumor compositions containing taxane derivatives. |
US5916596A (en) * | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
US6096331A (en) * | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
US6749868B1 (en) * | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
US5665382A (en) * | 1993-02-22 | 1997-09-09 | Vivorx Pharmaceuticals, Inc. | Methods for the preparation of pharmaceutically active agents for in vivo delivery |
US6537579B1 (en) * | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
US6753006B1 (en) * | 1993-02-22 | 2004-06-22 | American Bioscience, Inc. | Paclitaxel-containing formulations |
US5439686A (en) * | 1993-02-22 | 1995-08-08 | Vivorx Pharmaceuticals, Inc. | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor |
DK0693924T4 (en) * | 1993-02-22 | 2008-08-04 | Abraxis Bioscience Inc | Process for (in vivo) delivery of biological materials and compositions suitable therefor |
US5840746A (en) * | 1993-06-24 | 1998-11-24 | Merck Frosst Canada, Inc. | Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases |
US5523325A (en) | 1993-09-09 | 1996-06-04 | Jacobson; Richard M. | Amidrazones and their use as pesticides |
KR970703306A (en) | 1994-06-03 | 1997-07-03 | 슈타르크, 카르크 | Carbamoyl Carboxylic Acid Hydrazides and Their Use Against Fungi |
CA2166676C (en) * | 1995-01-09 | 2007-05-01 | Yasuhisa Fujibayashi | Diagnostic agent for hypoxia or mitochondrial dysfunction comprising radioactive copper complex of dithiosemicarbazone derivative or diamine diol schiff base derivative |
ATE184613T1 (en) * | 1995-09-22 | 1999-10-15 | Novo Nordisk As | VARIANTS OF GREEN FLUORESCENCE PROTEIN, GFP |
US5739686A (en) * | 1996-04-30 | 1998-04-14 | Naughton; Michael J. | Electrically insulating cantilever magnetometer with mutually isolated and integrated thermometry, background elimination and null detection |
US5753200A (en) * | 1996-10-07 | 1998-05-19 | Solvay Minerals, Inc. | Sodium metabisulfite process |
US6235787B1 (en) * | 1997-06-30 | 2001-05-22 | Hoffmann-La Roche Inc. | Hydrazine derivatives |
GB9727524D0 (en) | 1997-12-31 | 1998-02-25 | Pharmacia & Upjohn Spa | Synergistic antitumor composition containing a biologically active ureido compound |
TW479053B (en) * | 1998-10-19 | 2002-03-11 | Agro Kanesho Co Ltd | Hydrazineoxoacetamide derivatives and pesticides |
ES2161594B1 (en) * | 1998-12-17 | 2003-04-01 | Servier Lab | NEW DERIVATIVES OF HYDRAZIDE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
US6322303B1 (en) * | 2000-05-12 | 2001-11-27 | David M. John | Dunnage bag and method of making same |
EP1164126A1 (en) * | 2000-06-16 | 2001-12-19 | Basf Aktiengesellschaft | Salicylic acid hydrazide derivatives, process and intermediates for their preparation, agents containing them and their use for combatting damaging fungi |
US6365745B1 (en) * | 2000-07-14 | 2002-04-02 | Sumika Fine Chemicals Co., Ltd. | Method for producing hydrazine derivative |
MXPA03006666A (en) * | 2001-01-25 | 2004-05-31 | Guilford Pharm Inc | Trisubstituted carbocyclic cyclophilin binding compounds and their use. |
CA2445967A1 (en) * | 2001-05-01 | 2002-11-07 | Abbott Laboratories | Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents |
WO2002094259A1 (en) * | 2001-05-03 | 2002-11-28 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation |
US6602907B1 (en) * | 2001-06-08 | 2003-08-05 | University Of Central Florida | Treatment of breast cancer |
EP1405841B1 (en) * | 2001-06-20 | 2006-08-16 | Kuraray Co., Ltd. | Process for preparation of 2-oxocarboxylic acid esters |
TWI332943B (en) * | 2001-07-10 | 2010-11-11 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
US6924312B2 (en) * | 2001-07-10 | 2005-08-02 | Synta Pharmaceuticals Corp. | Taxol enhancer compounds |
TWI252847B (en) | 2001-07-10 | 2006-04-11 | Synta Pharmaceuticals Corp | Synthesis of taxol enhancers |
TWI297335B (en) * | 2001-07-10 | 2008-06-01 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
MXPA02010231A (en) * | 2001-11-27 | 2004-12-13 | Warner Lambert Co | Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases. |
ES2330927T3 (en) * | 2001-11-28 | 2009-12-17 | Ipsen Pharma | DERIVATIVES OF 5-SULFANIL-4H-1,2,4-TRIAZOLS TO TREAT SOMATOSTATIN ASSOCIATED DISORDERS. |
TW200408407A (en) | 2001-11-30 | 2004-06-01 | Dana Farber Cancer Inst Inc | Methods and compositions for modulating the immune system and uses thereof |
KR100958618B1 (en) * | 2002-12-31 | 2010-05-20 | 동부일렉트로닉스 주식회사 | method for forming a semiconductor device |
AU2006228035B2 (en) | 2003-01-15 | 2010-02-18 | Synta Pharmaceuticals Corp. | Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer |
TWI330079B (en) | 2003-01-15 | 2010-09-11 | Synta Pharmaceuticals Corp | Treatment for cancers |
ES2393483T3 (en) | 2003-02-11 | 2012-12-21 | Vernalis (R&D) Limited | Isoxazole compounds as heat shock protein inhibitors |
KR100575251B1 (en) | 2003-03-03 | 2006-05-02 | 재단법인서울대학교산학협력재단 | Pharmaceutical composition for treatment of cancer containing p38/JTV-1 as an effective component and screening method for pharmaceutical composition for treatment of cancer |
EP1493445A1 (en) | 2003-07-04 | 2005-01-05 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Inhibition of stress-induced ligand-dependent EGFR activation |
AR045595A1 (en) | 2003-09-04 | 2005-11-02 | Vertex Pharma | USEFUL COMPOSITIONS AS INHIBITORS OF KINASE PROTEINS |
KR100544347B1 (en) * | 2003-12-11 | 2006-01-23 | 한국생명공학연구원 | Pharmaceutical compositions of diaryl-isoxazole compounds for the prevention and treatment of cancers |
WO2005097758A1 (en) | 2004-03-26 | 2005-10-20 | Amphora Discovery Corporation | Certain triazole-based compounds, compositions, and uses thereof |
JP5362986B2 (en) | 2004-06-23 | 2013-12-11 | シンタ ファーマスーティカルズ コーポレイション | Bis (thio-hydrazide amide) salts for cancer treatment |
WO2006033913A2 (en) | 2004-09-16 | 2006-03-30 | Synta Pharmaceuticals Corp. | Bis (thio-hydrazide amides) for treament of hyperplasia |
US8148426B2 (en) * | 2004-11-19 | 2012-04-03 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amides) for increasing Hsp70 expression |
WO2006062732A2 (en) | 2004-11-19 | 2006-06-15 | Synta Pharmaceuticals Corp. | Compounds acting at the centrosome |
JP5123671B2 (en) | 2005-02-17 | 2013-01-23 | シンタ ファーマシューティカルズ コーポレーション | Compounds for the treatment of proliferative diseases |
CA2603314A1 (en) | 2005-04-15 | 2006-10-26 | Synta Pharmaceuticals Corp. | Methods of increasing natural killer cell activity for therapy |
WO2006113493A2 (en) | 2005-04-15 | 2006-10-26 | Synta Pharmaceuticals Corp. | Methods of determining cancer prognosis via natural killer cell activity |
JP2008536875A (en) * | 2005-04-15 | 2008-09-11 | シンタ ファーマシューティカルズ コーポレーション | Combined cancer therapy with bis (thiohydrazide) amide compounds |
BRPI0611262A2 (en) | 2005-05-16 | 2010-08-24 | Synta Pharmaceuticals Corp | Methods of Preparing a Bis (Thiohydrazide Amide) Di-Salt |
AU2006279891B2 (en) | 2005-08-16 | 2010-03-11 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amide) formulation |
SI22254A (en) | 2006-04-13 | 2007-10-31 | Univerza V Ljubljani Fakulteta Za Farmacijo | New arylsulphonohydrazide murc and murd enzyme inhibitors |
US8497272B2 (en) | 2006-08-21 | 2013-07-30 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
AU2007288336B2 (en) * | 2006-08-21 | 2011-04-21 | Synta Pharmaceuticals Corp. | Bis(thiohydrazide amides) for use in preventing or delaying the recurrence of melanoma |
SG174087A1 (en) | 2006-08-21 | 2011-09-29 | Synta Pharmaceuticals Corp | Compounds for treating proliferative disorders |
WO2008024298A1 (en) | 2006-08-21 | 2008-02-28 | Synta Pharmaceuticals Corp. | Bis(thiohydrazide amides) for inhibiting angiogenesis |
WO2008024299A2 (en) | 2006-08-21 | 2008-02-28 | Synta Pharmaceuticals Corp. | Combination with bis(thiohydrazide amides) for treating cancer |
WO2008024305A2 (en) | 2006-08-21 | 2008-02-28 | Synta Pharmaceuticals Corp. | Bis (thiohydrazide amides) for treating melanoma |
EP2076254A2 (en) * | 2006-08-31 | 2009-07-08 | Synta Pharmaceuticals Corporation | Combination with bis(thiohydrazide amides) for treating cancer |
WO2008033300A2 (en) | 2006-09-11 | 2008-03-20 | Synta Pharmaceuticals Corp. | Bis (thiohydrazide amides) formulation |
EP2059250A2 (en) | 2006-09-14 | 2009-05-20 | Synta Pharmaceuticals Corporation | Compounds for the treatment of angiogenesis |
WO2008033494A2 (en) | 2006-09-15 | 2008-03-20 | Synta Pharmaceuticals Corp. | Purification of bis(thiohydrazide amides) |
WO2008082579A1 (en) | 2007-01-03 | 2008-07-10 | Synta Pharmaceuticals Corp. | Method for treating cancer |
US8093425B2 (en) * | 2007-04-30 | 2012-01-10 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
TW200922550A (en) | 2007-08-07 | 2009-06-01 | Synta Pharmaceuticals Corp | Compounds for treating proliferative disorders |
US8618170B2 (en) | 2007-11-09 | 2013-12-31 | Synta Pharmaceuticals Corp. | Oral formulations of bis(thiohydrazide amides) |
WO2009073148A2 (en) | 2007-11-28 | 2009-06-11 | Synta Pharmaceuticals Corp. | Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide) |
TW200940050A (en) * | 2007-11-28 | 2009-10-01 | Synta Pharmaceuticals Corp | Polymorphs of N-malonyl-bis(N'-methyl-N'-thiobenzoylhydrazide) |
-
2002
- 2002-07-09 TW TW091115205A patent/TWI252847B/en not_active IP Right Cessation
- 2002-07-10 EP EP02746946A patent/EP1406868A1/en not_active Ceased
- 2002-07-10 US US10/193,076 patent/US6825235B2/en not_active Expired - Fee Related
- 2002-07-10 WO PCT/US2002/021716 patent/WO2003006429A1/en active Application Filing
- 2002-07-10 CN CNB02817724XA patent/CN100398516C/en not_active Expired - Fee Related
- 2002-07-10 CN CNA2008100928683A patent/CN101270069A/en active Pending
- 2002-07-10 CA CA002453415A patent/CA2453415A1/en not_active Abandoned
- 2002-07-10 KR KR10-2004-7000333A patent/KR20040026679A/en not_active Application Discontinuation
- 2002-07-10 AU AU2002316625A patent/AU2002316625B2/en not_active Ceased
- 2002-07-10 MX MXPA04000245A patent/MXPA04000245A/en not_active Application Discontinuation
- 2002-07-10 JP JP2003512201A patent/JP2004534847A/en active Pending
-
2004
- 2004-01-07 NO NO20040053A patent/NO20040053L/en not_active Application Discontinuation
- 2004-03-24 US US10/807,919 patent/US7074952B2/en not_active Expired - Fee Related
-
2006
- 2006-05-24 US US11/440,429 patent/US7435843B2/en not_active Expired - Fee Related
- 2006-08-24 AU AU2006203689A patent/AU2006203689A1/en not_active Abandoned
-
2008
- 2008-08-29 US US12/231,217 patent/US7652168B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH482394A (en) * | 1966-09-14 | 1969-12-15 | Shell Int Research | Herbicidal agent |
Non-Patent Citations (10)
Cited By (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7652168B2 (en) | 2001-07-10 | 2010-01-26 | Synta Pharmaceuticals Corp. | Synthesis of taxol enhancers |
US7750042B2 (en) | 2001-07-10 | 2010-07-06 | Synta Pharmaceuticals Corp. | Paclitaxel enhancer compound |
US7671092B2 (en) | 2001-07-10 | 2010-03-02 | Synta Pharmaceuticals Corp. | Paclitaxel enhancer compounds |
US7763658B2 (en) | 2003-01-15 | 2010-07-27 | Synta Pharmaceuticals Corp. | Treatment for cancers |
US8048925B2 (en) | 2004-06-23 | 2011-11-01 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amide) salts for treatment of cancers |
US8461208B2 (en) | 2004-06-23 | 2013-06-11 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amide) salts for treatment of cancers |
US7579503B2 (en) | 2004-06-23 | 2009-08-25 | Synta Pharmaceuticals Corp. | BIS (thio-hydrazide amide) salts for treatment of cancers |
JP2008504264A (en) * | 2004-06-23 | 2008-02-14 | シンタ ファーマスーティカルズ コーポレイション | Bis (thio-hydrazide amide) salts for cancer treatment |
US7795313B2 (en) | 2004-06-23 | 2010-09-14 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amide) salts for treatment of cancers |
US8017654B2 (en) | 2005-04-15 | 2011-09-13 | Synta Pharmaceuticals Corp. | Combination cancer therapy with bis(thiohydrazide) amide compounds |
US8623921B2 (en) | 2005-08-16 | 2014-01-07 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amide) formulation |
US7678832B2 (en) | 2005-08-16 | 2010-03-16 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amide) formulation |
US9156783B2 (en) | 2006-08-21 | 2015-10-13 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
US7939564B2 (en) | 2006-08-31 | 2011-05-10 | Synta Pharmaceuticals Corp. | Combination with bis(thiohydrazide amides) for treating cancer |
US7645904B2 (en) | 2006-09-15 | 2010-01-12 | Synta Pharmaceuticals Corp. | Purification of bis(thiohydrazide amides) |
WO2009073148A2 (en) * | 2007-11-28 | 2009-06-11 | Synta Pharmaceuticals Corp. | Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide) |
WO2009073148A3 (en) * | 2007-11-28 | 2009-10-15 | Synta Pharmaceuticals Corp. | Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide) |
US8637704B2 (en) | 2007-11-28 | 2014-01-28 | Synta Pharmaceuticals Corp. | Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide) |
US20140350115A1 (en) * | 2007-11-28 | 2014-11-27 | Synta Pharmaceuticals Corp. | Polymorphs of n-malonyl-bis(n`-methyl-n`-thiobenzoylhydrazide) |
US9051250B2 (en) * | 2007-11-28 | 2015-06-09 | Synta Pharmaceuticals Corp. | Polymorphs of N-malonyl-bis(N′-methyl-N′-thiobenzoylhydrazide) |
WO2009123704A3 (en) * | 2008-03-31 | 2009-12-10 | Synta Pharmaceuticals Corp. | Process for preparing bis(thiohydrazide amides) |
WO2009123704A2 (en) * | 2008-03-31 | 2009-10-08 | Synta Pharmaceuticals Corp. | Process for preparing bis(thiohydrazide amides) |
WO2013144228A1 (en) | 2012-03-29 | 2013-10-03 | Basf Se | Pesticidal methods using heterocyclic compounds and derivatives for combating animal pests |
Also Published As
Publication number | Publication date |
---|---|
AU2006203689A1 (en) | 2006-09-14 |
US7652168B2 (en) | 2010-01-26 |
CN101270069A (en) | 2008-09-24 |
AU2002316625B2 (en) | 2006-05-25 |
US20030069225A1 (en) | 2003-04-10 |
CN100398516C (en) | 2008-07-02 |
CN1553893A (en) | 2004-12-08 |
US20090005594A1 (en) | 2009-01-01 |
US7074952B2 (en) | 2006-07-11 |
NO20040053L (en) | 2004-02-10 |
MXPA04000245A (en) | 2005-03-07 |
CA2453415A1 (en) | 2003-01-23 |
EP1406868A1 (en) | 2004-04-14 |
US20060281811A1 (en) | 2006-12-14 |
US7435843B2 (en) | 2008-10-14 |
US20040229952A1 (en) | 2004-11-18 |
TWI252847B (en) | 2006-04-11 |
US6825235B2 (en) | 2004-11-30 |
JP2004534847A (en) | 2004-11-18 |
KR20040026679A (en) | 2004-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1406868A1 (en) | Synthesis of taxol enhancers | |
AU2002316625A1 (en) | Synthesis of taxol enhancers | |
RU2198656C2 (en) | Sulfated amino acid derivatives and metalloproteinase inhibitors comprising thereof | |
US7071219B2 (en) | Mono-acylated o-phenylendiamines derivatives | |
CA2397575A1 (en) | Antibacterial agents | |
EP1406869A1 (en) | Taxol enhancer compounds | |
CZ200425A3 (en) | Derivatives of aromatic dicarboxylic acids | |
AU2002316626A1 (en) | Taxol enhancer compounds | |
JP2001525392A (en) | Adamantane derivative | |
AU5650299A (en) | Benzene derivatives and medicinal use thereof | |
CA2507137A1 (en) | Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents | |
JPS6317823B2 (en) | ||
CN113087693B (en) | Nitrogen-containing biaryl ring compound, preparation method and application | |
US20030225043A1 (en) | Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same | |
US20020151718A1 (en) | Synthesis of pyrrole amides | |
RU2125040C1 (en) | Succinic acid derivatives, method of preparing same, intermediate compounds for synthesis thereof, and method of preparing intermediate compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003512201 Country of ref document: JP Ref document number: 2453415 Country of ref document: CA Ref document number: PA/a/2004/000245 Country of ref document: MX Ref document number: 1020047000333 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 77/DELNP/2004 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002316625 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002746946 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002817724X Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2002746946 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |